Photys Therapeutics
Photys Therapeutics is a clinical-stage biopharmaceutical company in Waltham, Massachusetts advancing proximity-based, targeted protein modulation medicines across three heterobifunctional modalities: PROTAC-based protein degradation (lead program PHT-776/HPB-143, an oral IRAK4 degrader that entered Phase I in August 2026 for autoimmune and inflammatory disease), PHICS (Phosphorylation-Inducing Chimeric Small molecules, partnered with Novo Nordisk since December 2024 for cardiometabolic disease), and tPRIME for restoring protective proteins such as p53 Y220C in oncology. Founded in 2022 out of Amit Choudhary's lab at the Broad Institute and Brigham and Women's Hospital with a $75M Series A led by MPM Capital and Longwood Fund. Photys operates no developer program and publishes no OpenAPI, GraphQL, AsyncAPI, WSDL or gRPC contract; its only machine-readable, agent-facing surface is the platform-provided Wix Site MCP endpoint served from its own host at www.photys.com/_api/mcp, which answers anonymously with nine tools over site content and business details.
Photys Therapeutics is listed with 1 API on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Drug Discovery, and Life Sciences.
Photys Therapeutics’ developer surface includes authentication and 9 more developer resources.
Kin Score
Standards implemented 2
Standards this provider implements or carries. De facto ones are profiled and measured by the API Commons; formal ones come from the standards directory and are linked by the provider's own tags. The evidence column says how each claim was established — not that it was made.
APIs 1
Individual APIs this provider publishes, each with its own machine-readable definition.
Photys Site MCP
The Wix-platform Site MCP server Photys serves from its own production host. Nine tools over public site content — business details, in-site search, site API docs discovery, an ...
MCP Servers 1
Model Context Protocol servers that expose these APIs to AI agents.
Site Visitor Assistant for site "Photys"
Remote MCP server at www.photys.com; 10 tools listed.
MCP SERVERPhotys Therapeutics API pricing
Pricing Plans 1
Published pricing tiers and plan structures.
Rate Limits 1
Documented rate limits and quota policies.
Photys Therapeutics Rate Limits
RATE LIMITSSecurity Posture 2
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 2
MCP servers, agent skills, and machine-readable catalogs
Design & Contract 2
Pagination, idempotency, versioning, errors, and events
Build 1
SDKs, sample code, and the tooling you integrate with
Access & Security 2
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 1
Pricing, plans, and the legal terms of use
Company 1
The organization behind the API
Source (apis.yml)
Photys Therapeutics API — frequently asked questions
Does Photys Therapeutics have an API?
Yes. APIs.io lists 1 API from Photys Therapeutics, including Photys Site MCP.
How do I authenticate with the Photys Therapeutics API?
Photys Therapeutics uses bearer-token authentication (0 schemes). The details are profiled on APIs.io as Photys Therapeutics Authentication.
Does Photys Therapeutics have an MCP server?
Yes. APIs.io lists 1 MCP server for Photys Therapeutics: Remote MCP server at www.photys.com; 10 tools listed.
Is the Photys Therapeutics API ready for AI agents?
Photys Therapeutics has a Kin Score of 12.6 out of 100 (emerging) and an Agent Readiness score of 7.2 (agent-aware), scored by API Evangelist on 2026-11-06.
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.